IDEXX Laboratories Statistics
Total Valuation
IDXX has a market cap or net worth of $38.08 billion. The enterprise value is $38.66 billion.
Important Dates
The last earnings date was Monday, February 3, 2025, before market open.
| Earnings Date | Feb 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IDXX has 81.88 million shares outstanding. The number of shares has decreased by -0.87% in one year.
| Current Share Class | 81.88M |
| Shares Outstanding | 81.88M |
| Shares Change (YoY) | -0.87% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 92.21% |
| Float | 80.99M |
Valuation Ratios
The trailing PE ratio is 43.58 and the forward PE ratio is 38.93. IDXX's PEG ratio is 2.65.
| PE Ratio | 43.58 |
| Forward PE | 38.93 |
| PS Ratio | 9.84 |
| Forward PS | 9.16 |
| PB Ratio | 23.86 |
| P/TBV Ratio | 23.87 |
| P/FCF Ratio | 47.12 |
| P/OCF Ratio | 40.99 |
| PEG Ratio | 2.65 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 30.76, with an EV/FCF ratio of 47.84.
| EV / Earnings | 43.54 |
| EV / Sales | 9.92 |
| EV / EBITDA | 30.76 |
| EV / EBIT | 34.26 |
| EV / FCF | 47.84 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.31 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 1.07 |
| Interest Coverage | 60.97 |
Financial Efficiency
Return on equity (ROE) is 57.66% and return on invested capital (ROIC) is 28.13%.
| Return on Equity (ROE) | 57.66% |
| Return on Assets (ROA) | 21.52% |
| Return on Invested Capital (ROIC) | 28.13% |
| Return on Capital Employed (ROCE) | 50.70% |
| Revenue Per Employee | $354,319 |
| Profits Per Employee | $80,715 |
| Employee Count | 11,000 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 3.98 |
Taxes
In the past 12 months, IDXX has paid $221.96 million in taxes.
| Income Tax | 221.96M |
| Effective Tax Rate | 20.00% |
Stock Price Statistics
The stock price has decreased by -11.78% in the last 52 weeks. The beta is 1.37, so IDXX's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -11.78% |
| 50-Day Moving Average | 425.88 |
| 200-Day Moving Average | 467.95 |
| Relative Strength Index (RSI) | 67.32 |
| Average Volume (20 Days) | 777,651 |
Short Selling Information
The latest short interest is 1.73 million, so 2.11% of the outstanding shares have been sold short.
| Short Interest | 1.73M |
| Short Previous Month | 1.50M |
| Short % of Shares Out | 2.11% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 3.30 |
Income Statement
In the last 12 months, IDXX had revenue of $3.90 billion and earned $887.87 million in profits. Earnings per share was $10.67.
| Revenue | 3.90B |
| Gross Profit | 2.38B |
| Operating Income | 1.13B |
| Pretax Income | 1.06B |
| Net Income | 887.87M |
| EBITDA | 1.26B |
| EBIT | 1.13B |
| Earnings Per Share (EPS) | $10.67 |
Full Income StatementBalance Sheet
The company has $288.27 million in cash and $867.57 million in debt, giving a net cash position of -$579.31 million or -$7.07 per share.
| Cash & Cash Equivalents | 288.27M |
| Total Debt | 867.57M |
| Net Cash | -579.31M |
| Net Cash Per Share | -$7.07 |
| Equity (Book Value) | 1.60B |
| Book Value Per Share | 19.49 |
| Working Capital | 331.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $929.00 million and capital expenditures -$120.92 million, giving a free cash flow of $808.08 million.
| Operating Cash Flow | 929.00M |
| Capital Expenditures | -120.92M |
| Free Cash Flow | 808.08M |
| FCF Per Share | $9.87 |
Full Cash Flow StatementMargins
Gross margin is 61.04%, with operating and profit margins of 28.95% and 22.78%.
| Gross Margin | 61.04% |
| Operating Margin | 28.95% |
| Pretax Margin | 28.48% |
| Profit Margin | 22.78% |
| EBITDA Margin | 32.24% |
| EBIT Margin | 28.95% |
| FCF Margin | 20.73% |